SHILPAMEDNSEShilpa Medicare Limited· Pharmaceuticals & BiotechnologyHighPositive
Announced Mon, 6 Oct, 2025 · 09:28 IST

Shilpa Medicare approves 1:1 bonus issue of 97.79 million shares

SHILPAMED · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-1.9%Reaction day
₹386.40
prior close
₹382.80
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.3%-1.6% vs market
Pharmaceuticals peers, median of 154sector-0.3%-1.7% vs sector

On the reaction day the stock moved 1.6 pts less than Nifty Microcap 250 and 1.7 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
+0.1
15m
-0.2
30m
-1.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-1.9-0.3-1.6-0.3-1.7
Next day
-4.9-0.5-4.4-0.8-4.2
2d
-7.1-0.8-6.3-1.1-6.0
3d
-3.7-0.6-3.1-0.4-3.3
4d
-3.9+0.1-4.0-0.1-3.9
5d
-5.0-0.5-4.6-0.8-4.2
1w
-7.7-0.6-7.1-1.3-6.4
15d
-6.8+1.3-8.0-1.5-5.3
1m
-5.4-0.2-5.2-1.9-3.5
2m
-16.0-6.8-9.2-6.1-9.9
3m
-17.6-3.4-14.2-5.3-12.2
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

On October 6, 2025, the board committee approved the allotment of 97,790,908 fully paid bonus shares of Rs 1 each to shareholders of record on October 3, 2025. The ratio is one bonus share for every existing share. Paid-up share capital will double from Rs 97.79 million to Rs 195.58 million.

Likely market impact

Shareholders' share count will double, but there is no cash payment. The share price and profit per share will normally adjust proportionately after bonus allotment.